Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.
about
Pharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme InhibitorsA dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed stateThe effect of food on the bioavailability of panobinostat, an orally active pan-histone deacetylase inhibitor, in patients with advanced cancer.Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors.In vitro and in vivo pharmacokinetic characterizations of AMG 900, an orally bioavailable small molecule inhibitor of aurora kinases.Description of current practices of empiric chemotherapy dose adjustment in obese adult patients.Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products.Possible interactions between dietary fibres and 5-aminosalicylic acid [corrected]Safe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panelIslamic fasting and multiple sclerosis.Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients.Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp.Drug interactions in cancer therapy.Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patients.Effects of food on the relative bioavailability of lapatinib in cancer patients.The Effect of a High-Fat Meal on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or Lymphoma.Bitter melon extracts enhance the activity of chemotherapeutic agents through the modulation of multiple drug resistance.Drug interactions in metastatic breast cancer.The role of diet on the clinical pharmacology of oral antineoplastic agents.Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters.Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement.Adherence to oral antineoplastic agents by cancer patients: definition and literature review.Optimizing dosing of oncology drugs.Food Effect Studies for Oncology Drug Products.Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tablets.Plasma Pharmacokinetics of Veledimex, a Small-Molecule Activator Ligand for a Proprietary Gene Therapy Promoter System, in Healthy Subjects.Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake: In Silico and Clinical Evaluations.A Review of Food-Drug Interactions on Oral Drug Absorption.Supplementation of fish oil augments efficacy and attenuates toxicity of 5-fluorouracil in 1,2-dimethylhydrazine dihydrochloride/dextran sulfate sodium-induced colon carcinogenesis.Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake Conditions.Pharmacokinetics of Venetoclax, a Novel BCL-2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma.A Phase 1, Randomized, Single-Dose Crossover Pharmacokinetic Study to Investigate the Effect of Food Intake on Absorption of Orteronel (TAK-700) in Healthy Male Subjects.Comparison of the pharmacokinetics of erlotinib administered in complete fasting and 2 h after a meal in patients with lung cancer.Lack of significant food effect on the pharmacokinetics of ticagrelor in healthy volunteers.Influence of a fat-rich meal on bioavailability of extended-release and immediate-release propiverine.Food Effect on Oral Bioavailability: Old and New Questions.Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumours.
P2860
Q28554328-80ED7545-7054-4FF2-87DB-A894FE7E5E48Q33390197-7E2BCA95-3D19-477F-8198-2816CA02C7B0Q33398014-79AAA1C4-63AD-4854-8FAC-F3A5FC84EE4DQ33428581-439F8A00-944C-4445-956E-5FEC6A34BF5CQ33811937-4CF40645-EE83-4D49-9407-2BCE01E799FFQ33846184-2A9A65B9-D7C7-4BAF-8253-E4E0F9A1B4F6Q34101250-FD4C4513-36B5-45CC-B393-0943BB66C045Q34409123-7D9CF2A8-3F8C-43D8-B5A2-4155DDD9F3FCQ34459756-566A89DB-EE54-4B2E-AC67-5CFA0F0EB3BBQ35127335-8B493350-2A4C-46C1-B6B6-AEFF13E2CD0CQ35747766-7EBAB89E-76DA-46B2-82C7-D1CCB8393C69Q35852614-3F678A6E-28E0-455A-9E89-13D7A92C7342Q36516421-DC786A07-91D8-40C7-9374-EDCBFF6823BAQ36906428-0DC3671E-CCFD-4181-B267-E021DC4DB6BCQ36938561-07CFB785-2358-4161-BDE2-FCB64ED6B483Q37348913-0D1F385F-584C-4F96-A626-94F8F24B789AQ37610933-532A164F-EECD-4B74-B724-9D7E8F80C49CQ37791284-E33A8E90-164B-46B0-9C38-260EE8022609Q37907103-95E2C85C-203C-406A-9E0F-4203D52DFE48Q37993631-03486356-4556-486A-8119-BA5DCFE743BCQ38082728-92BAD499-9F82-4276-B360-BFA1F9C35DA5Q38147533-79EE59C6-5886-4083-A7C5-E555F4CCF57FQ38238161-210B4A8E-FF39-49B0-B453-38DD4477E3BAQ39078280-776B5B4C-0950-4BC2-AD0B-6C32BD6E8D67Q42613593-0F76E962-1AAF-408A-A9F3-78561A19BF2AQ45855827-D394D9EA-225C-44A5-8C12-845C0DA2222EQ46297172-4B05F154-B0D9-433C-BA22-B457A7A46C60Q48117745-4F576040-AF71-43F1-9ABD-398A2AD878AFQ48276385-9D754FB1-F570-48E9-B7D7-15230A458BD7Q50711101-039C570C-973C-409D-993D-A02FFFBDFD24Q51280033-CB7AF27A-A99A-4596-B4F6-016321665785Q51284848-EAB721FF-6821-4B50-AC3C-175584D37B8BQ51302682-B4CFE3F3-C5C7-401E-95A5-A69671607664Q51367258-9282C808-AA40-414E-A4D2-BDFF00E54119Q51373576-95A3D040-4F81-46EF-854E-76890154EBC7Q53370868-AB1F18F7-A5C4-4B92-ABF1-CD63DD52A004Q54389879-6254550F-08DD-4BA5-8DF5-BAA0DA38CAF7
P2860
Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Effects of food on the clinica ...... cations for oral chemotherapy.
@ast
Effects of food on the clinica ...... cations for oral chemotherapy.
@en
type
label
Effects of food on the clinica ...... cations for oral chemotherapy.
@ast
Effects of food on the clinica ...... cations for oral chemotherapy.
@en
prefLabel
Effects of food on the clinica ...... cations for oral chemotherapy.
@ast
Effects of food on the clinica ...... cations for oral chemotherapy.
@en
P1476
Effects of food on the clinica ...... cations for oral chemotherapy.
@en
P2093
Bimal K Malhotra
Brahma N Singh
P304
P356
10.2165/00003088-200443150-00005
P577
2004-01-01T00:00:00Z
P6179
1045485539